Literature DB >> 8440606

Association of Chlamydia trachomatis with tubal infertility.

R N Roberts1, A J Quinn, W Thompson, R D Maw, D E Wyatt, R B Beattie.   

Abstract

A study was undertaken to determine whether the positive correlation between Chlamydia trachomatis antibodies and tubal infertility, noted by workers in other countries, also applied to infertile women in Northern Ireland. Ninety-one infertile women and 106 fertile controls were tested for current cervical infection with C. trachomatis and for evidence of past chlamydial infection. The incidence of C. trachomatis infection of the cervix was 5.8% in the infertile group and 2.8% in the control group. The prevalence of C. trachomatis antibody was 22% in the infertile group and 18.9% in the control group. Previous termination of pregnancy, history of sexually transmitted disease and number of sexual partners were identified as risk factors for seropositivity and tubal disease. We concluded that it would be of value to screen women attending the infertility clinic for C. trachomatis infection of the cervix, and that testing these patients for chlamydia antibodies may also be useful in planning further investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440606     DOI: 10.1007/bf02942825

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  18 in total

1.  Chlamydial serology in women with tubal infertility.

Authors:  M E Kelver; M Nagamani
Journal:  Int J Fertil       Date:  1989 Jan-Feb

2.  Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease.

Authors:  D E Moore; L R Spadoni; H M Foy; S P Wang; J R Daling; C C Kuo; J T Grayston; D A Eschenbach
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

3.  Antispermatozoal antibodies in men with urethritis.

Authors:  M Shahmanesh; J Stedronska; W F Hendry
Journal:  Fertil Steril       Date:  1986-08       Impact factor: 7.329

4.  Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial.

Authors:  W E Stamm; H R Harrison; E R Alexander; L D Cles; M R Spence; T C Quinn
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

5.  Detection of Chlamydia trachomatis antigens by enzyme immunoassay and immunofluorescence in genital specimens from symptomatic and asymptomatic men and women.

Authors:  M A Chernesky; J B Mahony; S Castriciano; M Mores; I O Stewart; S J Landis; W Seidelman; E J Sargeant; C Leman
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

6.  Chlamydia trachomatis: its role in tubal infertility.

Authors:  R C Brunham; I W Maclean; B Binns; R W Peeling
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

Review 7.  Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.

Authors:  L Weström
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

8.  Genital infections with Chlamydia trachomatis in women attending an antenatal clinic.

Authors:  P L Wood; D Hobson; E Rees
Journal:  Br J Obstet Gynaecol       Date:  1984-12

9.  Correlation between serum antichlamydial antibodies and tubal factor as a cause of infertility.

Authors:  R B Jones; B R Ardery; S L Hui; R E Cleary
Journal:  Fertil Steril       Date:  1982-11       Impact factor: 7.329

10.  Prevalence of Chlamydia trachomatis infection in women having cervical smear tests.

Authors:  J R Smith; J Murdoch; D Carrington; C E Frew; A J Dougall; H MacKinnon; D Baillie; D M Byford; C A Forrest; J A Davis
Journal:  BMJ       Date:  1991-01-12
View more
  1 in total

1.  Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: a global systematic review and meta-analysis.

Authors:  Weiming Tang; Jessica Mao; Katherine T Li; Jennifer S Walker; Roger Chou; Rong Fu; Weiying Chen; Toni Darville; Jeffrey Klausner; Joseph D Tucker
Journal:  Sex Transm Infect       Date:  2019-12-13       Impact factor: 3.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.